401 related articles for article (PubMed ID: 30271079)
1. Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis.
Yang F; Chen GX
World J Gastroenterol; 2018 Sep; 24(36):4132-4151. PubMed ID: 30271079
[TBL] [Abstract][Full Text] [Related]
2. Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity.
Ferry G; Tellier E; Try A; Grés S; Naime I; Simon MF; Rodriguez M; Boucher J; Tack I; Gesta S; Chomarat P; Dieu M; Raes M; Galizzi JP; Valet P; Boutin JA; Saulnier-Blache JS
J Biol Chem; 2003 May; 278(20):18162-9. PubMed ID: 12642576
[TBL] [Abstract][Full Text] [Related]
3. Polyunsaturated lysophosphatidic acid as a potential asthma biomarker.
Ackerman SJ; Park GY; Christman JW; Nyenhuis S; Berdyshev E; Natarajan V
Biomark Med; 2016; 10(2):123-35. PubMed ID: 26808693
[TBL] [Abstract][Full Text] [Related]
4. Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy.
Brindley DN; Lin FT; Tigyi GJ
Biochim Biophys Acta; 2013 Jan; 1831(1):74-85. PubMed ID: 22954454
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling.
Zhao Y; Natarajan V
Cell Signal; 2009 Mar; 21(3):367-77. PubMed ID: 18996473
[TBL] [Abstract][Full Text] [Related]
6. Autotaxin facilitates selective LPA receptor signaling.
Salgado-Polo F; Borza R; Matsoukas MT; Marsais F; Jagerschmidt C; Waeckel L; Moolenaar WH; Ford P; Heckmann B; Perrakis A
Cell Chem Biol; 2023 Jan; 30(1):69-84.e14. PubMed ID: 36640760
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid (LPA) receptor-mediated signaling and cellular responses to anticancer drugs and radiation of cancer cells.
Ikeda H; Takai M; Tsujiuchi T
Adv Biol Regul; 2024 May; 92():101029. PubMed ID: 38377635
[TBL] [Abstract][Full Text] [Related]
8. Comparative analyses of lysophosphatidic acid receptor-mediated signaling.
Fukushima N; Ishii S; Tsujiuchi T; Kagawa N; Katoh K
Cell Mol Life Sci; 2015 Jun; 72(12):2377-94. PubMed ID: 25732591
[TBL] [Abstract][Full Text] [Related]
9. LPA and Autotaxin: Potential Drug Targets in Asthma?
Georas SN
Cell Biochem Biophys; 2021 Sep; 79(3):445-448. PubMed ID: 34331220
[TBL] [Abstract][Full Text] [Related]
10. Autotaxin-lysophosphatidic acid receptor 5 axis evokes endothelial dysfunction via reactive oxygen species signaling.
Janovicz A; Majer A; Kosztelnik M; Geiszt M; Chun J; Ishii S; Tigyi GJ; Benyó Z; Ruisanchez É
Exp Biol Med (Maywood); 2023 Oct; 248(20):1887-1894. PubMed ID: 37837357
[TBL] [Abstract][Full Text] [Related]
11. Linking the Autotaxin-LPA Axis to Medicinal Cannabis and the Endocannabinoid System.
Eymery MC; Boumendjel A; McCarthy AA; Hausmann J
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542186
[TBL] [Abstract][Full Text] [Related]
12. Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target.
Ntatsoulis K; Karampitsakos T; Tsitoura E; Stylianaki EA; Matralis AN; Tzouvelekis A; Antoniou K; Aidinis V
Front Immunol; 2021; 12():687397. PubMed ID: 34671341
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid receptor-dependent secondary effects via astrocytes promote neuronal differentiation.
Spohr TC; Choi JW; Gardell SE; Herr DR; Rehen SK; Gomes FC; Chun J
J Biol Chem; 2008 Mar; 283(12):7470-9. PubMed ID: 18198181
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the enzyme autotaxin reduces cortical excitability and ameliorates the outcome in stroke.
Bitar L; Uphaus T; Thalman C; Muthuraman M; Gyr L; Ji H; Domingues M; Endle H; Groppa S; Steffen F; Koirala N; Fan W; Ibanez L; Heitsch L; Cruchaga C; Lee JM; Kloss F; Bittner S; Nitsch R; Zipp F; Vogt J
Sci Transl Med; 2022 Apr; 14(641):eabk0135. PubMed ID: 35442704
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid: receptors, signaling and survival.
Swarthout JT; Walling HW
Cell Mol Life Sci; 2000 Dec; 57(13-14):1978-85. PubMed ID: 11215523
[TBL] [Abstract][Full Text] [Related]
16. Autotaxin and Lysophosphatidate Signaling: Prime Targets for Mitigating Therapy Resistance in Breast Cancer.
Benesch MGK; Tang X; Brindley DN; Takabe K
World J Oncol; 2024 Feb; 15(1):1-13. PubMed ID: 38274724
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid modulates CD8 T cell immunosurveillance and metabolism to impair anti-tumor immunity.
Turner JA; Fredrickson MA; D'Antonio M; Katsnelson E; MacBeth M; Van Gulick R; Chimed TS; McCarter M; D'Alessandro A; Robinson WA; Couts KL; Pelanda R; Klarquist J; Tobin RP; Torres RM
Nat Commun; 2023 Jun; 14(1):3214. PubMed ID: 37270644
[TBL] [Abstract][Full Text] [Related]
18. Altered ovarian tissue level of lysophosphatidic acid and mRNA expressions of its metabolic enzymes and receptors in rats received gonadotropin-hyperstimulation.
Yamamoto-Mikami A; Tanaka Y; Tsutsumi T; Kuwahara A; Tokumura A
Reprod Biol; 2024 Mar; 24(1):100849. PubMed ID: 38306852
[TBL] [Abstract][Full Text] [Related]
19. Alpha-substituted phosphonate analogues of lysophosphatidic acid (LPA) selectively inhibit production and action of LPA.
Jiang G; Xu Y; Fujiwara Y; Tsukahara T; Tsukahara R; Gajewiak J; Tigyi G; Prestwich GD
ChemMedChem; 2007 May; 2(5):679-90. PubMed ID: 17443831
[TBL] [Abstract][Full Text] [Related]
20. Phosphoproteomics Reveals Selective Regulation of Signaling Pathways by Lysophosphatidic Acid Species in Macrophages.
Dietze R; Szymanski W; Ojasalu K; Finkernagel F; Nist A; Stiewe T; Graumann J; Müller R
Cells; 2024 May; 13(10):. PubMed ID: 38786034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
